EW Q4 2019 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+20.1% YoY

Gross Profit

$879M74.8% margin

Operating Income

$337M28.7% margin

Net Income

$280M23.9% margin

EPS (Diluted)

$0.44

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

$399M

Free Cash Flow

$328M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$6.5B

Total Liabilities

$2.3B

Stockholders' Equity

$4.1B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$978M	+20.1%
Gross Profit	$879M	$742M	+18.5%
Operating Income	$337M	$290M	+16.2%
Net Income	$280M	$7M	+3902.9%

Revenue Segments

Transcatheter Heart Valves

$763M65%

Surgical Heart Valve Therapy

$205M17%

Critical Care

$199M17%

Transcatheter Mitral And Tricuspid Therapies

$7M1%

Geographic Segments

UNITED STATES

$697M59%

Europe

$242M21%

JAPAN

$120M10%

Rest of World

$114M10%